| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |